Business & Finance
Elsevier faces trial in $1 billion defamation lawsuit over air purifier study
A federal judge allowed claims by Global Plasma Solutions to proceed, setting a December 7 trial date over allegations of publishing a flawed academic paper.
The short version
- Global Plasma Solutions (GPS Air) is suing scientific publisher Elsevier for $1 billion over a 2021 study regarding its air purification technology.
- The lawsuit survived dismissal after federal judges found GPS plausibly alleged actual malice, and a trial is set for December 7.
- GPS alleges Elsevier ignored peer review standards when publishing the paper, causing the company substantial financial losses.
Key facts
- A federal trial date has been set for December 7 in a $1 billion defamation lawsuit filed by Global Plasma Solutions (GPS Air) against publisher Elsevier.[Slashdot]
- GPS filed the lawsuit in 2022 after Elsevier declined to retract a 2021 study published in the journal Building and Environment concerning GPS's needlepoint bipolar ionization technology.[Slashdot]
- GPS claims the paper contained omitted data and misleading conclusions that caused the company significant financial losses, alleging Elsevier published the study knowing it failed peer review standards.[Slashdot]
- U.S. Magistrate Judge David Keesler issued a May 2024 opinion stating GPS plausibly alleged actual malice, which was upheld in July 2025 by Chief Judge Martin Reidinger of the U.S. District Court for the Western District of North Carolina.[Slashdot]
- A judge has previously imposed a $10,000 sanction against Elsevier during the course of the litigation.[Slashdot]
- Citing discovery materials, GPS alleges that Elsevier published over 1,200 articles across 19 journals without peer review or against reviewer recommendations.[Slashdot]
What remains uncertain
- Whether GPS can legally establish actual malice and liability against Elsevier during the December 7 trial remains to be determined.[Slashdot]